Branicka A - Search Results

1

FcepsilonRIalpha gene -18483A>C polymorphism affects transcriptional activity through YY1 binding.

Potaczek DP, Maeda K, Wang QH, Nakano N, Kanada S, Stepien E, Branicka A, Fukai T, Hara M, Tokura T, Ogawa H, Undas A, Okumura K, Nishiyama C. Potaczek DP, et al. Among authors: branicka a. Immunogenetics. 2009 Sep;61(9):649-55. doi: 10.1007/s00251-009-0391-x. Epub 2009 Aug 14. Immunogenetics. 2009. PMID: 19685047

2

Very rare minor homozygous GG genotype of tissue factor +5466A>G mutation in a patient with two cryptogenic cerebrovascular ischemic events.

Potaczek DP, Pieculewicz M, Mazur M, Branicka A, Nishiyama C, Okumura K, Undas A. Potaczek DP, et al. Among authors: branicka a. Int J Cardiol. 2011 Feb 17;147(1):e13-5. doi: 10.1016/j.ijcard.2009.01.009. Epub 2009 Feb 8. Int J Cardiol. 2011. PMID: 19203804

3

Tissue factor +5466A>G polymorphism predicts plasma TF levels in subjects with cryptogenic ischaemic stroke.

Potaczek DP, Pieculewicz M, Mazur M, Branicka A, Nishiyama C, Okumura K, Podolec P, Undas A. Potaczek DP, et al. Among authors: branicka a. Thromb Haemost. 2009 Jul;102(1):173-5. doi: 10.1160/TH09-02-0099. Thromb Haemost. 2009. PMID: 19572083 No abstract available.

4

A vitamin K epoxide reductase-oxidase complex gene polymorphism (-1639G>A) and interindividual variability in the dose-effect of vitamin K antagonists.

Stepien E, Branicka A, Ciesla-Dul M, Undas A. Stepien E, et al. Among authors: branicka a. J Appl Genet. 2009;50(4):399-403. doi: 10.1007/BF03195700. J Appl Genet. 2009. PMID: 19875892

5

[Optimalisation of treatment with vitamin K antagonists--the role of gene polymorphisms].

Stępień E, Wypasek E, Branicka A, Undas A. Stępień E, et al. Among authors: branicka a. Kardiol Pol. 2010;68 Suppl 5:S428-35. Kardiol Pol. 2010. PMID: 22134997 Review. Polish.

6

Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin.

Undas A, Stepień E, Branicka A, Wołkow P, Zmudka K, Tracz W. Undas A, et al. Among authors: branicka a. Kardiol Pol. 2009 Jun;67(6):591-8. Kardiol Pol. 2009. PMID: 19618315 Clinical Trial.

7

Genetic determinants of acenocoumarol and warfarin maintenance dose requirements in Slavic population: a potential role of CYP4F2 and GGCX polymorphisms.

Wypasek E, Branicka A, Awsiuk M, Sadowski J, Undas A. Wypasek E, et al. Among authors: branicka a. Thromb Res. 2014 Sep;134(3):604-9. doi: 10.1016/j.thromres.2014.06.022. Epub 2014 Jul 7. Thromb Res. 2014. PMID: 25042728

8

[Chlamydia pneumoniae infections--diagnostic methods].

Stepień E, Pieniazek P, Branicka A, Bozek M. Stepień E, et al. Among authors: branicka a. Przegl Lek. 2002;59(3):142-6. Przegl Lek. 2002. PMID: 12184026 Review. Polish.

9

The +405 GG variant of vascular endothelial growth factor polymorphism is associated with poor prognosis in patients undergoing coronary artery bypass graft surgery.

Pastuszczak M, Branicka A, Jakiela B, Stepień E, Jaworek AK, Wojas-Pelc A, Kapelak B, Sadowski J. Pastuszczak M, et al. Among authors: branicka a. Pol Arch Med Wewn. 2009 Nov;119(11):719-25. Pol Arch Med Wewn. 2009. PMID: 19920796 Free article.

10

[The thrombin generation is associated with the PIA1/A2 beta3, integrin polymorphism in aspirin-treated patients with coronary artery disease: a role of statins].

Stepień E, Szułdrzyński K, Branicka A, Stankiewicz E, Pazdan A, Zieliński L, Bozek M, Tomala M, Guzik B, Godlewski J, Pawelec T, Zmudka K. Stepień E, et al. Among authors: branicka a. Pol Arch Med Wewn. 2007 Jan-Feb;117(1-2):33-40. Pol Arch Med Wewn. 2007. PMID: 17642204 Free article. Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page